TP53, SF3B1, and NOTCH1 mutations and outcome of allotransplantation for chronic lymphocytic leukemia: six-year follow-up of the GCLLSG CLL3X trial.

Dreger, Peter

TP53, SF3B1, and NOTCH1 mutations and outcome of allotransplantation for chronic lymphocytic leukemia: six-year follow-up of the GCLLSG CLL3X trial. [electronic resource] - Blood Apr 2013 - 3284-8 p. digital

Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't

1528-0020

10.1182/blood-2012-11-469627 doi


Adult
Aged
Disease-Free Survival
Female
Follow-Up Studies
Hematopoietic Stem Cell Transplantation--methods
Humans
Leukemia, Lymphocytic, Chronic, B-Cell--genetics
Male
Middle Aged
Mutation
Phosphoproteins--genetics
RNA Splicing Factors
Receptor, Notch1--genetics
Ribonucleoprotein, U2 Small Nuclear--genetics
Transplantation, Homologous--methods
Treatment Outcome
Tumor Suppressor Protein p53--genetics